ERBB2 and neoplasm: Prognosis is the sum of clinical aspects such as patient age, lymph node status, and tumor size; histological features, namely, grade and lymphovascular invasion; division into molecular subtypes by hormone receptor status, HER2 status, and proliferative index (Ki67).